Escherichia coli AcrB is a multidrug efflux transporter that recognizes multiple toxic chemicals and expels them from cells. It is a proton antiporter belonging to the resistance-nodulation-division (RND) superfamily. Asp407, Asp408, Lys940, and Arg971 in transmembrane (TM) helices of this transporter have been identified as essential amino acid residues that probably function as components of the proton relay system. In this study, we identified a novel residue in TM helix 11, Thr978, as an essential residue by alanine scanning mutagenesis. Its location close to Asp407 suggests that it is also a component of the proton translocation pathway, a prediction confirmed by the similar conformations adopted by T978A, D407A, D408A, and K940A mutant proteins (see the accompanying paper). Sequence alignment of 566 RND transporters showed that this threonine residue is conserved in about 96% of cases. Our results suggest the hypotheses that Thr978 functions through hydrogen bonding with Asp407 and that protonation of the latter alters the salt bridging and hydrogen bonding pattern in the proton relay network, thus initiating a series of conformational changes that ultimately result in drug extrusion.Multidrug transporters cause serious problems in the chemotherapy of cancer as well as in the antibiotic treatment of bacterial infections. These membrane proteins recognize many structurally dissimilar toxic compounds and actively extrude them from the cell. The Escherichia coli AcrB transporter (10, 11), which is a member of the resistance-nodulation-division (RND) family of transporters (26), is responsible for most of the intrinsic drug resistance of this organism (14,15,22) and is one of the best-studied multidrug pumps. It occurs as a multiprotein complex (24,25,32), with an outer membrane channel TolC protein (4, 9) and a periplasmic linker protein, AcrA (10), and this complex structure allows the direct export of drugs to the external medium (14). The structural work of Murakami et al. (12) revealed that unbound AcrB is a homotrimer, where each subunit contains 12 transmembrane (TM) helices and two large periplasmic domains, between TM1 and TM2 and between TM7 and TM8. The top of the periplasmic domain of AcrB is thought to associate with TolC.AcrB utilizes proton motive force (PMF) as energy for its transport function (10,30,31). The molecular mechanism that couples proton translocation to the efflux of drugs has not been elucidated completely. However, the simplest mechanism seems to operate in a small multidrug transporter, EmrE, of E. coli (19,23,28). In this transporter, there exists only one membrane-embedded charged residue, Glu14, and this residue is involved in the recognition of both the substrates and the coupling proton. For another well-studied PMF-dependent transporter, the lactose permease LacY from E. coli (1), the proton translocation pathway involves several charged residues in the TM helices and is separate from the substrate transport pathway.Charged residues embedded in the membrane were also show...